IMCHECK THERAPEUTICS

ImCheck Therapeutics is a developer of immuno-modulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric, ovarian cancer cells and other solid solid tumours.

#SimilarOrganizations #People #Financial #Event #Website #More

IMCHECK THERAPEUTICS

Social Links:

Linkedin

Twitter

Industry:

Biopharma Biotechnology Health Care Life Science Therapeutics

Founded:

2015-01-01

Address:

Marseille, Provence-Alpes-Cote D'Azur, France

Country:

France

Website Url:

http://www.imchecktherapeutics.com

Total Employee:

11+

Status:

Active

Contact:

+33 4 13 96 14 90

Total Funding:

172.93 M EUR

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics

Similar Organizations

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

autobahn-therapeutics-logo

Autobahn Therapeutics

Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.

Current Advisors List

daniel-olive_image

Daniel Olive Scientific Advisor @ ImCheck Therapeutics
Advisor
2015-01-01

florent-gros_image

Florent Gros Board Member @ ImCheck Therapeutics
Board_member

raphaël-wisniewski_image

Raphaël Wisniewski Board Member @ ImCheck Therapeutics
Board_member

Current Employees Featured

pierre-depenoux_image

Pierre d’Epenoux
Pierre d’Epenoux Chief Executive Officer @ ImCheck Therapeutics
Chief Executive Officer
2016-12-01

alem-truneh_image

Alem Truneh
Alem Truneh Chief Technology Officer @ ImCheck Therapeutics
Chief Technology Officer
2015-03-01

benjamin-charles_image

Benjamin Charles
Benjamin Charles Chief Business Officer @ ImCheck Therapeutics
Chief Business Officer
2015-09-01

rene-hoet_image

Rene Hoet
Rene Hoet Chief Scientific Officer @ ImCheck Therapeutics
Chief Scientific Officer
2018-10-01

emmanuel-valentin_image

Emmanuel Valentin
Emmanuel Valentin Director Translational Medicine @ ImCheck Therapeutics
Director Translational Medicine
2019-07-01

paul-frohna_image

Paul Frohna
Paul Frohna Chief Medical Officer @ ImCheck Therapeutics
Chief Medical Officer
2019-06-01

claude-knopf_image

Claude Knopf
Claude Knopf Chief Business Officer @ ImCheck Therapeutics
Chief Business Officer
2020-06-01

Founder

alem-truneh_image

Alem Truneh

benjamin-charles_image

Benjamin Charles

daniel-olive_image

Daniel Olive

Investors List

pfizer-venture-investments_image

Pfizer Venture Investments

Pfizer Venture Investments investment in Series C - ImCheck Therapeutics

eurazeo-com_image

Eurazeo

Eurazeo investment in Series C - ImCheck Therapeutics

life-sciences-partners_image

Life Sciences Partners

Life Sciences Partners investment in Series C - ImCheck Therapeutics

wellington-partners_image

Wellington Partners

Wellington Partners investment in Series C - ImCheck Therapeutics

boehringer-ingelheim-venture-fund_image

Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund investment in Series C - ImCheck Therapeutics

bpifrance_image

Bpifrance

Bpifrance investment in Series C - ImCheck Therapeutics

pureos-bioventures_image

Pureos Bioventures

Pureos Bioventures investment in Series C - ImCheck Therapeutics

invus_image

Invus

Invus investment in Series C - ImCheck Therapeutics

leukemia-lymphoma-society_image

Leukemia & Lymphoma Society

Leukemia & Lymphoma Society investment in Series C - ImCheck Therapeutics

earlybird-venture-capital_image

Earlybird Venture Capital

Earlybird Venture Capital investment in Series C - ImCheck Therapeutics

Key Employee Changes

Date	New article
2020-07-09	ImCheck Therapeutics Appoints Claude Knopf as Chief Business Officer

Official Site Inspections

http://www.imchecktherapeutics.com Semrush global rank: 8.75 M Semrush visits lastest month: 261

Host Informations
Whois Informations

Loading ...

More informations about "ImCheck Therapeutics" on Search Engine